Page 33 - The Indian EYE 062725

Newsmakers of the Week JUNE 27, 2025 | The Indian Eye 33

Dr. Srinivas Mukkamala Makes History as AMA President

WASHINGTON, DC:
inaugural address.
“We need physician leaders unit-
r. Srinivas Mukkamala has ed in purpose—and the AMA’s voice
become the first person of
DIndian origin to be elected has never been more necessary.”
The AMA also adopted new pol-
President of the American Medical icies under his leadership, including
Association (AMA), marking a his- better nutrition education to reduce
toric moment in the organization’s reliance on ultraprocessed foods.
178-year history. Dr. Mukkamala’s lived experience
A practicing otolaryngologist,
Dr. Mukkamala took office in Chica- and advocacy reinforce a renewed
commitment to equity and compas-
go amid a personal battle with brain sion in American healthcare.
cancer. Diagnosed last year with an
8-cm tumor in his temporal lobe,
he underwent surgery that removed To read more about
90% of it.
This experience reaffirmed his Indian diaspora and Global Indians,
dedication to improving America’s log on to and follow our website
healthcare system, particularly in affordability. impossible decisions about costs, de- www.TheIndianEYE.com
addressing inequities in access and “Too many patients still face lays, and access,” he said during his

Tanya Mayadas

to Lead URMC’s New

Immunological Sciences

Institute

ROCHESTER, NY:

r. Tanya N. Mayadas has
been appointed Chair of the
DDepartment of Microbiology
and Immunology at the University of
Rochester Medical Center (URMC)
and the founding Director of its new
Institute for Immunological Sciences,
effective August 1, 2025.
A UR alumna, Mayadas earned
her PhD in Biochemistry at Roches-
ter before moving to Harvard Med-
ical School, where she served as a
tenured professor and led pioneering
research at Brigham and Women’s
Hospital. Her return to Rochester
signals a major investment in advanc-
ing translational immunology.

Her lab investigates immune cell activity during inflammation and au-
toimmune diseases, especially glomerulonephritis, a leading cause

of kidney failure. At URMC, she plans to expand research in immune
regulation, host-pathogen interactions, and cancer immunology.

The new Institute will bridge foundational science and clinical practice,
fostering collaboration, innovation, and cross-disciplinary training. “URMC
has the ideal environment to build a world-class immunology program,” Maya-
das said, emphasizing both scientific excellence and human connection in her
leadership vision.

www.TheIndianEYE.com